• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

(CSE:BNXT)

0.3000 UNCHANGED
Streaming Delayed Price Updated: 9:30 AM EDT, Aug 5, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about BNXT

< Previous 1 2 3 Next >
News headline image
BioNxt Receives Delivery of Premium Commercial Coating and Cutting Equipment for Commercial Manufacturing of Drug Delivery Products
December 12, 2023
Via ACCESSWIRE
News headline image
BioNxt Accelerates Cladribine ODF Clinical and Commercialization Strategy for Multiple Sclerosis Treament
November 20, 2023
Via ACCESSWIRE
News headline image
BioNxt Reports on New Cladrabine ODF Product Development and Commercialization Program
November 15, 2023
Via ACCESSWIRE
News headline image
BioNxt Signs Definitive Agreement For 100% Acquisition of IP And Co-Development of Cladribine ODF Drug Reformulation for The Treatment of Multiple Sclerosis
November 13, 2023
Via ACCESSWIRE
News headline image
BioNxt Solutions Announces Closing of Third and Final Tranche of Non-Brokered Private Placement
October 27, 2023
Via ACCESSWIRE
News headline image
BioNxt Signs LOI for Acquisition of IP and Co-Development of ODF Drug Reformulation for Neurodegenerative Disease
August 02, 2023
Via ACCESSWIRE
News headline image
BioNxt Receives Approval for European Clinical Study of Transdermal Rotigotine Patch for Parkinson’s Disease
May 15, 2023
Via ACCESSWIRE
News headline image
BioNxt Successfully Completes Pilot Study for Contract Development Customer
May 09, 2023
Via ACCESSWIRE
News headline image
BioNxt Secures Contract to Develop and Manufacture ODF Product for International Pharmaceutical Company
April 24, 2023
Via ACCESSWIRE
News headline image
BioNxt Acquires Commercial Coating and Cutting Equipment to Build Out European Commercial Manufacturing Capacity
April 17, 2023
Via ACCESSWIRE
News headline image
BioNxt Solutions Acquires Novel Precision Drug Coating and Delivery Technology
March 07, 2023
Via ACCESSWIRE
News headline image
BioNxt Signs Clinical Study Agreement and Commences Manufacture of Clinical Samples for Study of Transdermal Rotigotine Patch for Parkinson’s Disease
March 01, 2023
Via ACCESSWIRE
News headline image
BioNxt Reports Update on Commercialization of Rotigotine Patch for Treatment of Parkinson's Disease
February 13, 2023
Via ACCESSWIRE
InvestorNewsBreaks – BioNxt Solutions Inc. (CSE: BNXT) (OTCQB: XPHYF) (FSE: 4XT) to Expand Portfolio with Precision Drug Delivery Technology
December 12, 2022
Via Investor Brand Network
Topics Intellectual Property
News headline image
BioNxt Solutions Signs Term Sheet for Novel Precision Drug Coating Platform Technology
December 12, 2022
Via ACCESSWIRE
InvestorNewsBreaks – BioNxt Solutions Inc. (CSE: BNXT) (OTCQB: XPHYF) (FSE: 4XT) Holds Key Meetings, Advances Product at Frankfurt CPHI Conference
November 21, 2022
Via Investor Brand Network
Topics Supply Chain
News headline image
BioNxt Solutions Reports on Frankfurt CPHI Conference
November 21, 2022
Via ACCESSWIRE
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap